Navigation Links
QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
Date:3/31/2017

HILDEN, Germany and GERMANTOWN, Maryland, March 31, 2017 /PRNewswire/ --

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer. QIAGEN has acquired an exclusive worldwide license from Johns Hopkins University for detecting the AR-V7 biomarker in all sample and cell types through nucleic acid tests such as polymerase chain reaction (PCR) or next-generation sequencing (NGS). Johns Hopkins researchers have used AdnaTest technology in studies to evaluate the expression of AR-V7 messenger RNA in prostate cancer patients.

"Our AdnaTest workflow unlocks an important biomarker for clinical research to provide for the development of prostate cancer diagnostics in the future. Providing accurate insights from circulating tumor cells in a blood sample, our AR-V7 solution is a significant addition to our portfolio of non-invasive liquid biopsies for Personalized Healthcare," said Thierry Bernard, Senior Vice President and Head of QIAGEN's Molecular Diagnostics Business Area. "We are pleased to partner with the pioneering researchers at Johns Hopkins in developing this workflow. We plan to make the AdnaTest kit commercially available this year, as a Sample to Insight solution for clinical researchers."

Click here for the full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={55C014E9-91D1-4E5E-8FF0-822B2224081A}&lang=en

Contacts: 

QIAGEN 

Investor Relations            
John Gilardi    
+49-2103-29-11711        
e-mail: ir@QIAGEN.com             
           
Public Relations
Dr. Thomas Theuringer
+49-2103-29-11826  
e-mail: pr@QIAGEN.com


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
2. New Study Published in Lancet Respiratory Medicine Highlights QIAGENs QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants
3. QIAGENs QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits
4. How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta
5. QIAGEN Enhances Bioinformatics Portfolio with Acquisition of OmicSoft
6. QIAGEN Announces Comprehensive Range of Enhancements for GeneReader NGS System
7. Research and Markets - Global Cervical Cancer Diagnostic Testing Market Growth of 6%, 2016-2020 with Becton, Hologic & Qiagen Dominating
8. Research Reports Coverage on Services Stocks -- Myriad Genetics, Qiagen, INC Research, and La Quinta
9. QIAGEN GeneReader NGS System to Relaunch in U.S. Market
10. QIAGENs GeneReader NGS System Streamlines Data Management for Labs
11. QIAGEN führt Flüssigbiopsie-Workflow für das GeneReader NGS-System ein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2018)... AUSTIN, Texas (PRWEB) , ... October 17, 2018 ... ... Dental Implant Centers, has recently published a new technique documenting the use of ... placement of dental implants. According to Dr. Holtzclaw, “At our DIA Dental ...
(Date:10/17/2018)... ... 17, 2018 , ... The OMNISteth™ is the first stethoscope ... and intuitive adjustments maximize the sound quality and performance during an exam. , ... the body, which automatically adjusts the listening frequency range to the proper level. ...
(Date:10/16/2018)... ... 16, 2018 , ... Citrus Valley Health Partners and Keck School of Medicine ... on the health care ecosystem of the San Gabriel Valley. , With the ... and actionable solutions aimed at transforming the way health care is provided in the ...
Breaking Medicine Technology:
(Date:10/16/2018)... ... October 16, 2018 , ... ... loans, equipment leasing, and franchise financing , is now recognized by Massage ... Balboa Capital will structure and deliver custom-tailored financing programs to Massage Envy franchisees ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... mission to provide simple, easy-to-use software for biopharma companies. By pairing the InTime ... answer those crucial resourcing questions without spending millions of dollars implementing a complicated ...
(Date:10/16/2018)... ... October 16, 2018 , ... Sheba Vine, JD, CPCO, Vice ... law, writes frequently on employment law matters and has contributed articles to Compliance ... Health Care Compliance Professional's Manual titled “Navigating the Evolving Marijuana Landscape” to serve ...
(Date:10/16/2018)... ... October 16, 2018 , ... AutismOne, the nation’s largest and ... the 4th Annual International HPV Vaccine Education Symposium. , Presenters from countries around ... through Friday, May 24, 2019, with a keynote address from Robert F. Kennedy, ...
(Date:10/13/2018)... ... ... Convoy of Hope is positioned and ready to serve the communities in ... devastated Florida Panhandle to begin response operations following Hurricane Michael. Up to 50 additional ... supplies to those affected by the storm. , Hurricane Michael made landfall as ...
Breaking Medicine News(10 mins):